We performed sensitivity analyses for comorbidities that may interfere with NT‐proBNP clearance (chronic kidney disease, obesity), as well as in patients with isolated PMR after excluding mixed MR, and using a dichotomized NT‐proBNP threshold of 1000 ng/L. This evidence concerns the gene NPPB and obesity disorder.